Jazz Pharmaceuticals plc·4

Dec 11, 5:19 PM ET

Henderson Mary Elizabeth 4

4 · Jazz Pharmaceuticals plc · Filed Dec 11, 2025

Insider Transaction Report

Form 4
Period: 2025-12-09
Henderson Mary Elizabeth
SVP, Technical Operations
Transactions
  • Sale

    Ordinary Shares

    2025-12-09$169.51/sh2,238$379,36619,508 total
Footnotes (1)
  • [F1]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $169.00 to $169.82. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT